CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 165 filers reported holding CARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,905 | +14.7% | 736 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,889 | +2188.7% | 736 | +2130.3% | 0.00% | – |
| Q2 2022 | $301 | -97.7% | 33 | -97.0% | 0.00% | -100.0% |
| Q1 2022 | $13,219 | +70.4% | 1,088 | +70.8% | 0.01% | +66.7% |
| Q4 2021 | $7,759 | -17.4% | 637 | +4.8% | 0.00% | 0.0% |
| Q3 2021 | $9,394 | +10.6% | 608 | +2.2% | 0.00% | 0.0% |
| Q2 2021 | $8,491 | – | 595 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
| RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
| Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
| DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
| Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
| WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
| Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |